Form 4 for DMRA Damora Therapeutics, Inc.
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-09 · accession 0001209191-21-063798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-10 | 2021-11-09 | DMRA | Schambye Hans T. | CEO, Dir | P - Purchase | $3.50 | +4,500 | 47.4K | +10% | +$15.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-09 | P | A | 4,500 | $3.50 | 47,428 | D | — | — |